Sign in
8-K

Current Report

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-24-043130

Exit or restructuring costs · Impairment · Executive or director change · Regulation FD disclosure · Other events

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 2.06 Material impairments
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading form8-k.htm…